» Articles » PMID: 20729967

A 6% Benzoyl Peroxide Foaming Cloth Cleanser Used in the Treatment of Acne Vulgaris: Aesthetic Characteristics, Patient Preference Considerations, and Impact on Compliance with Treatment

Overview
Date 2010 Aug 24
PMID 20729967
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The study was conducted to evaluate the product attributes of a new benzoyl peroxide-containing foaming cloth cleanser and to compare the overall patient satisfaction of this product with two currently available benzoyl peroxide acne products (6% benzoyl peroxide cleanser and 4% benzoyl peroxide wash).

Design: This was a randomized, single-blind study.

Setting: Two clinical trial sites.

Participants: Male and female subjects (N=193) aged 17 to 30 years with a history of acne vulgaris were enrolled.

Measures: Subjects initially cleansed their face with the benzoyl peroxide foaming cloth and then completed a product-attribute survey. Following an interval of five minutes or more, subjects cleansed their face again using one of two randomly assigned comparator benzoyl peroxide-containing cleansing products and then completed a comparative survey. Survey results were tabulated and a top-two box analysis was performed.

Results: Following the use of the benzoyl peroxide-containing foaming cloth, 94 percent of the product-attribute responses were positive (p</=0.05). With respect to convenience, usability, and cosmetic elegance, the majority of subjects indicated a preference for the benzoyl peroxide foaming cloth compared to the 6% benzoyl peroxide cleanser and 4% benzoyl peroxide wash (for each, p</=0.05). There were no reports of adverse events.

Conclusion: These attributes supporting preference for the benzoyl peroxide foaming cloth cleanser may improve patient satisfaction with topical acne treatment resulting in improved patient compliance. (J Clin Aesthetic Dermatol. 2009;2(7):26-29.).

Citing Articles

-Acylsulfonamide: a valuable moiety to design new sulfa drug analogues.

Amador R, Tahrioui A, Barreau M, Lesouhaitier O, Smietana M, Clave G RSC Med Chem. 2023; 14(8):1567-1571.

PMID: 37593573 PMC: 10429802. DOI: 10.1039/d3md00229b.


Identifying and appraising patient-reported outcome measures on treatment satisfaction in acne: a systematic review.

van Zuuren E, Arents B, Miklas M, Schoones J, Tan J Br J Dermatol. 2020; 185(1):36-51.

PMID: 33176002 PMC: 8359297. DOI: 10.1111/bjd.19675.


Topical benzoyl peroxide for acne.

Yang Z, Zhang Y, Lazic Mosler E, Hu J, Li H, Zhang Y Cochrane Database Syst Rev. 2020; 3:CD011154.

PMID: 32175593 PMC: 7077870. DOI: 10.1002/14651858.CD011154.pub2.


Over-the-counter Acne Treatments: A Review.

Decker A, Graber E J Clin Aesthet Dermatol. 2012; 5(5):32-40.

PMID: 22808307 PMC: 3366450.

References
1.
Yan A . Current concepts in acne management. Adolesc Med Clin. 2006; 17(3):613-37. DOI: 10.1016/j.admecli.2006.06.014. View

2.
Berson D, Chalker D, Harper J, Leyden J, Shalita A, Webster G . Current concepts in the treatment of acne: report from a clinical roundtable. Cutis. 2003; 72(1 Suppl):5-13. View

3.
Katsambas A . Why and when the treatment of acne fails. What to do. Dermatology. 1998; 196(1):158-61. DOI: 10.1159/000017851. View

4.
Date A, Naik B, Nagarsenker M . Novel drug delivery systems: potential in improving topical delivery of antiacne agents. Skin Pharmacol Physiol. 2005; 19(1):2-16. DOI: 10.1159/000089138. View

5.
Thiboutot D, Dreno B, Layton A . Acne counseling to improve adherence. Cutis. 2008; 81(1):81-6. View